WebJun 17, 2024 · In addition, HOOKIPA is building a proprietary immuno-oncology pipeline by targeting virally mediated cancer antigens, self-antigens and next-generation antigens. The TheraT ® based lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papilloma Virus 16-positive cancers. Web1 day ago · NEW YORK and VIENNA, Austria, April 14, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Compensation Committee of the Company’s Board of Directors approved the …
HOOKIPA Announces First Patient Enrolled in Phase 2 Trial
WebJan 18, 2024 · About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that … WebJan 18, 2024 · HOOKIPA’s pipeline includes wholly-owned investigational arenaviral immunotherapeutics targeting Human Papilloma Virus 16-positive cancers, prostate cancer, KRAS-mutated cancers (including ... pantene indonesia instagram
HOOKIPA Announces Grant of Inducement Awards Under …
WebDec 1, 2024 · In addition, HOOKIPA is building a proprietary immuno-oncology pipeline by targeting virally mediated cancer antigens, self-antigens and next-generation antigens. The lead replicating arenavirus oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papilloma Virus 16-positive cancers in a Phase … Webpipeline. ISA Pharmaceuticals focuses on the development of SLP®-based therapies for unmet medical needs in cancer and persistent viral infections. This strategy has resulted in a diverse portfolio with advanced clinical-stage SLP® immunotherapeutics for various cancer indications. The primary focus of the Company is the development of its ... WebNov 14, 2024 · HOOKIPA’s pipeline includes its wholly owned investigational arenaviral immunotherapies targeting Human Papillomavirus 16-positive cancers, prostate cancers, and other undisclosed programs. エンジンガード